Skip to main content

Table 4 Demographics and clinical characteristics of patients undergoing lateral lymph node dissection

From: Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients

Clinicopathological properties

 

Lateral lymph node metastasis

 

Total

No

 

Yes

 

Subjects, n

 

420

209

49.8%

211

50.2%

Gender

Female

329

172

52.3%

157

47.7%

Male

91

37

40.7%

54

59.3%

Age (years)

≤35

121

48

39.7%

73

60.3%

35–45

104

52

50.0%

52

50.0%

45–55

108

56

51.9%

52

48.1%

> 55

87

53

60.9%

34

39.1%

Tumor size(cm)

≤0.5

35

24

68.6%

11

31.4%

0.5–1.0

137

82

59.9%

55

40.1%

1.0–2.0

147

69

46.9%

78

53.1%

> 2.0

101

34

33.7%

67

66.3%

Ultrasound feature

 Microcalcification

No

277

144

52.0%

133

48.0%

Yes

143

65

45.5%

78

54.5%

 Hypoechoic solid nodules

No

73

33

45.2%

40

54.8%

Yes

347

176

50.7%

171

49.3%

 Irregular shape

No

259

131

50.6%

128

49.4%

Yes

161

78

48.4%

83

51.6%

 Infiltrative margins

No

95

48

50.5%

47

49.5%

Yes

325

161

49.5%

164

50.5%

 Intra-nodular vascularity

No

114

57

50.0%

57

50.0%

Yes

306

152

49.7%

154

50.3%

Multifocality

No

272

142

52.2%

130

47.8%

Yes

148

67

45.3%

81

54.7%

Bilateral

No

315

163

51.7%

152

48.3%

Yes

105

46

43.8%

59

56.2%

Extrathyroidal extension

No

286

153

53.5%

133

46.5%

Yes

134

56

41.8%

78

58.2%

Distant metastasis

No

416

207

49.8%

209

50.2%

Yes

4

2

50.0%

2

50.0%

Hashimoto’s thyroiditis

No

251

130

51.8%

121

48.2%

Yes

169

79

46.7%

90

53.3%

The number of CLNM

0

186

130

69.9%

56

30.1%

1–3

> 3

165

69

68

11

41.2%

15.9%

97

58

58.8%

84.1%

TSH value

  

2.20 ± 1.66

2.16 ± 1.44